KLK3 and neoplasm: We have observed across multiple datasets that in comparison to low-grade disease, in high-grade disease the physiologically benign AR ‘transcriptome’ is systematically suppressed and at least for the most highly expressed AR-regulated gene, the clinically utilised tumour marker KLK3/PSA, this effect is also observed at the protein level and has prognostic relevance.